It has been found that about 72% of squamous cell carcinoma of the head and neck involves the mutation of the TP53 gene which could be one of the major contributing factors toward the resistance to cisplatin chemotherapy [2]. This evidence concerns the gene TP53 and squamous cell carcinoma.